Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2002-3-21
pubmed:abstractText
1. Currents through heteromeric P2X(2/3) receptors were evoked by applying alpha,beta-methylene-ATP to human embryonic kidney cells transfected with cDNAs encoding the P2X(2) and P2X(3) subunits. The concentration of alpha,beta-methylene-ATP were < or =30 microM because higher concentrations can activate homomeric P2X(2) receptors. The kinetics of action of three structurally unrelated antagonists were studied; these were 2', 3'-O-(2,4,6,trinitrophenyl)-ATP (TNP-ATP), pyridoxal-5-phosphate-6-azophenyl-2',4'-disulphonate (PPADS) and suramin. The association and dissociation rate constants were determined by pre-applying the antagonist for various periods prior to the co-application of agonist and antagonist, or by changing the solution from one containing only the agonist to one containing both agonist and antagonist. The high affinity of TNP-ATP for the P2X(2/3) receptor (K(D) approximately 2 nM) results from fast binding (k(+1) approximately 100 microM(-1) s(-1)) rather than slow unbinding (k(-1) approximately 0.3 s(-1)). For suramin (K(D) approximately 1 microM) the association rate constant ( approximately 1 microM(-1) s(-1)) was 100 times slower than that of TNP-ATP but the dissociation rate constant was similar (k(-1) approximately 1 s(-1)). PPADS (K(D) approximately 0.1 microM) associated and dissociated some 100 - 10,000 times more slowly than the other antagonists.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10531403, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10699083, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10805655, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10823099, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10827197, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10836147, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10869706, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10869713, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10869734, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-10940304, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-11069181, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-11069182, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-11093790, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-11156581, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-11181939, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-11906944, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-6123358, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-7544432, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-7566120, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-7602533, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-8598206, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9011607, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9168113, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9364478, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9575290, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9606184, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9614197, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9632352, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9828090, http://linkedlifedata.com/resource/pubmed/commentcorrection/11906966-9987019
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2',3'-O-(2,4,6-trinitro-cyclohexadie..., http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Fluorescent Dyes, http://linkedlifedata.com/resource/pubmed/chemical/P2RX2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/P2RX3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/P2rx2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/P2rx3 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P2 Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Pyridoxal Phosphate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2X2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2X3, http://linkedlifedata.com/resource/pubmed/chemical/Suramin, http://linkedlifedata.com/resource/pubmed/chemical/pyridoxal...
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
135
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1524-30
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.
pubmed:affiliation
Institute of Molecular Physiology, University of Sheffield, Alfred Denny Building, Western Bank, Sheffield S10 2TN, UK.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't